Measuring skin water loss predicts anaphylaxis during food allergy tests

The method aims to detect the life threatening reaction before epinephrine injections are necessary

10:19 AM

Author | Patricia DeLacey

white bowls with allergens in each one
Getty Images

Food allergies can quickly turn a casual meal into a life-threatening situation.

Anaphylaxis – a severe allergic reaction that may include a skin rash, nausea, vomiting, difficulty breathing, and shock – from a food allergy sends 200,000 people to the emergency room annually in the United States.

Because pinpointing a food allergy could mean life or death, an accurate diagnosis is critical.

Oral food challenges – when a patient ingests increasing doses up to a full serving of the suspected food allergen under supervision of a medical provider – are the diagnostic standard as skin and blood allergy tests have high false positive rates.

Although a highly accurate diagnostic test, patients often experience anaphylaxis during oral food challenges necessitating an epinephrine injection.

SEE ALSO: Vaccine suppresses peanut allergies in mice

A team of University of Michigan researchers developed a method that measures water loss from the skin to predict anaphylaxis during oral food challenges before it becomes clinically evident.

The results are published in The Journal of Clinical Investigation.

“This method could enhance the ability to detect and predict anaphylaxis during oral food challenges prior to the need for epinephrine, greatly improving patient safety and comfort,” said Charles Schuler, M.D., lead author of the study and an immunologist at Michigan Medicine.

Building on existing research

During anaphylaxis, the dilation or widening of the blood vessels increases heat and water loss from the surface of the skin.

Previous research has assessed facial thermography, which uses a specialized camera to detect heat patterns emitted from the skin, as a method to predict anaphylaxis.

However, this method requires optics expertise, tightly controlled conditions and for the patient to sit still for an extended period – making this an impractical choice, especially for assessing food allergies in children.

The researchers validated the use of transepidermal water loss, a measurement that represents the amount of water that escapes from a given skin area per hour, by comparing its ability to detect anaphylaxis with biochemical and clinical observation methods.

They found that transepidermal water loss increases during food allergy reactions and anaphylaxis.

The rise in skin water loss correlated with biochemical markers of anaphylaxis and substantially preceded clinical detection of anaphylaxis.

SEE ALSO: The Do’s and Don’ts of Preventing Peanut Allergies in Babies

“Transepidermal water loss measurement can be done in office without specialized equipment, affixed to the skin and works in children making it a vast improvement from previous attempts at early anaphylaxis detection methods,” said Schuler.

Schuler’s research group is currently recruiting participants aged 6 months to 5 years old for a pilot clinical trial, Predicting Peanut Anaphylaxis and Reducing Epinephrine, that monitors transepidermal water loss from the forearm during a peanut allergy food challenge.

Results will help pinpoint values associated with anaphylaxis to determine “stopping rules” to end oral food challenges, hopefully reducing the need for epinephrine injections.

In addition to Schuler, the University of Michigan research team included Kelly O’Shea, M.D., Jonathan Troost, Ph.D., Bridgette Kaul, Christoper Launius, Jayme Cannon, David Manthei, M.D., George Freigeh, M.D., Georgiana Sanders, M.D., M.S., Simon Hogan, Ph.D., Nicholas Lukacs, Ph.D., and James Baker Jr., M.D.

This study was made possible in part by the University of Michigan Medical School Central Biorepository.

Paper cited: “Transepidermal water loss rises before food anaphylaxis and predicts food challenge outcomes,” Journal of Clinical Investigation. DOI: 10.1172/JCI168965


More Articles About: All Research Topics Basic Science and Laboratory Research Food Allergy Anaphylaxis (IgE) Allergy Testing Allergy and Immunology Allergic Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories stethoscope blue yellow
Health Lab
Researchers uncover novel mechanism that leads to high blood pressure
Researchers at Michigan Medicine have uncovered a key mechanism that regulates blood pressure and vascular remodeling in people with a genetic variant linked to high blood pressure.
purple white
Health Lab
Study defines key driver of aggressive ovarian cancer
A study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.
pill being taken close up with water near hand
Health Lab
Patients are opting in for 10 years of breast cancer treatment
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.
mom with sick child on phone checking tempature
Health Lab
Drug that treats flu shows additional benefit of protecting close contacts from infection
One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about 30%, according to research.
cells spikey on pink background purple spikes
Health Lab
New clinical trials for pediatric brain tumors
Brain and spinal cord tumors account for one in four childhood cancers. Although 75% of children survive for at least five years after being diagnosed, many patients have recurrent tumors that cannot be cured. Andrea Franson discusses current therapies for pediatric brain tumors, how viruses can be used to target tumor cells and the new phase 1 trial that started in May 2025.
red background person laying on ground with machine over looking into body organs appearing on screen
Health Lab
Histotripsy stimulates the immune system to attack cancer cells outside the liver
The University of Michigan Health pioneered the treatment histotripsy for liver cancer, which is helping teach the immune system which cancer cells to attack.